share_log

UroGen Pharma Ltd | 424B5: Prospectus

SEC ·  Dec 2, 2022 05:05
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more